Miao He

Miao He, PhD MBA, currently serves as a Senior Associate at Hadean Ventures, a European life science venture capital firm with approximately EUR 250 million in assets under management, since August 2021. Miao holds key positions as a Board Observer at Neuro Event Labs Oy and previously at Cardior Pharmaceuticals during a significant acquisition by Novo Nordisk. Prior experience includes an Associate role at Luminous Ventures and an MBA Consultant role at Ori Biotech, which focuses on innovations in cell and gene therapy manufacturing. Miao began a career in investment with a Summer Associate position at OurCrowd, recognized as Israel's most active venture capital firm. Earlier roles include Project Consultant at Cancer Research UK and various positions at Illumina, culminating in a Bioinformatics Scientist II role. Miao completed a PhD in Molecular Biology at the University of Cambridge and an MBA at the London Business School, following a BSc in Biological Sciences from Fudan University.